Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries

Background Outbreaks of vaccine-preventable diseases frequently occur in low and middle-income countries (LMICs), requiring outbreak response immunisation (ORI) programmes for containment. To inform future investment decisions, this study aimed to estimate the cases, deaths, disability-adjusted life...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefanie Vaccher, Romesh G Abeysuriya, Nick Scott, Dominic Delport, Tewodaj Mengistu, Alina M Muellenmeister, Gabrielle MacKechnie, Dan Hogan
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/10/7/e016887.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849415168158597120
author Stefanie Vaccher
Romesh G Abeysuriya
Nick Scott
Dominic Delport
Tewodaj Mengistu
Alina M Muellenmeister
Gabrielle MacKechnie
Dan Hogan
author_facet Stefanie Vaccher
Romesh G Abeysuriya
Nick Scott
Dominic Delport
Tewodaj Mengistu
Alina M Muellenmeister
Gabrielle MacKechnie
Dan Hogan
author_sort Stefanie Vaccher
collection DOAJ
description Background Outbreaks of vaccine-preventable diseases frequently occur in low and middle-income countries (LMICs), requiring outbreak response immunisation (ORI) programmes for containment. To inform future investment decisions, this study aimed to estimate the cases, deaths, disability-adjusted life years (DALYs) and societal economic costs averted by past ORI programmes. Outbreaks of measles, Ebola, yellow fever, cholera and meningococcal meningitis in LMICs between 2000 and 2023 were considered.Methods 210 outbreaks (51 measles, 40 cholera, 88 yellow fever, 24 meningitis, 7 Ebola) across 49 LMICs were identified with sufficient data for analysis. Data were sourced from publicly available outbreak reports and literature. Agent-based models were calibrated for each disease such that after controlling for baseline vaccine coverage, response time, vaccination rate, environmental variables or endemic prevalence of the disease, observed outbreaks were within the distribution of simulated outbreaks. A status-quo and no ORI scenario were compared for each outbreak.Findings Across 210 outbreaks, ORI programmes are estimated to have averted 5.81M (95% uncertainty interval 5.75M–5.87M) cases (4.01M measles, 283K cholera, 1.50M yellow fever, 21.3K meningitis, 820 Ebola), 327K (317K–338K) deaths (20.0K measles, 5215 cholera, 300K yellow fever, 1599 meningitis, 381 Ebola), 14.6M (14.1M–15.1M) DALYs (1.27M measles, 220K cholera, 13.0M yellow fever, 113K meningitis, 16.6K Ebola) and US$31.7B (29.0B–34.9B) (US$710M measles, US$156M cholera, US$30.7B yellow fever, US$97.6M meningitis, US$6.72M Ebola) in economic costs. Often, the more rapidly the ORI was initiated the greater impact.Interpretation ORI programmes are critical for reducing the health and economic impacts of outbreaks of vaccine-preventable diseases.
format Article
id doaj-art-5daebc2c20c94e64a8970c9da26da9d7
institution Kabale University
issn 2059-7908
language English
publishDate 2025-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Global Health
spelling doaj-art-5daebc2c20c94e64a8970c9da26da9d72025-08-20T03:33:37ZengBMJ Publishing GroupBMJ Global Health2059-79082025-07-0110710.1136/bmjgh-2024-016887Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countriesStefanie Vaccher0Romesh G Abeysuriya1Nick Scott2Dominic Delport3Tewodaj Mengistu4Alina M Muellenmeister5Gabrielle MacKechnie6Dan Hogan71 Burnet Institute, Melbourne, Victoria, Australia1 Burnet Institute, Melbourne, Victoria, Australia1 Burnet Institute, Melbourne, Victoria, Australia1 Burnet Institute, Melbourne, Victoria, Australia4 Gavi, the Vaccine Alliance, Geneva, Switzerland1 Burnet Institute, Melbourne, Victoria, Australia1 Burnet Institute, Melbourne, Victoria, Australia4 Gavi, the Vaccine Alliance, Geneva, SwitzerlandBackground Outbreaks of vaccine-preventable diseases frequently occur in low and middle-income countries (LMICs), requiring outbreak response immunisation (ORI) programmes for containment. To inform future investment decisions, this study aimed to estimate the cases, deaths, disability-adjusted life years (DALYs) and societal economic costs averted by past ORI programmes. Outbreaks of measles, Ebola, yellow fever, cholera and meningococcal meningitis in LMICs between 2000 and 2023 were considered.Methods 210 outbreaks (51 measles, 40 cholera, 88 yellow fever, 24 meningitis, 7 Ebola) across 49 LMICs were identified with sufficient data for analysis. Data were sourced from publicly available outbreak reports and literature. Agent-based models were calibrated for each disease such that after controlling for baseline vaccine coverage, response time, vaccination rate, environmental variables or endemic prevalence of the disease, observed outbreaks were within the distribution of simulated outbreaks. A status-quo and no ORI scenario were compared for each outbreak.Findings Across 210 outbreaks, ORI programmes are estimated to have averted 5.81M (95% uncertainty interval 5.75M–5.87M) cases (4.01M measles, 283K cholera, 1.50M yellow fever, 21.3K meningitis, 820 Ebola), 327K (317K–338K) deaths (20.0K measles, 5215 cholera, 300K yellow fever, 1599 meningitis, 381 Ebola), 14.6M (14.1M–15.1M) DALYs (1.27M measles, 220K cholera, 13.0M yellow fever, 113K meningitis, 16.6K Ebola) and US$31.7B (29.0B–34.9B) (US$710M measles, US$156M cholera, US$30.7B yellow fever, US$97.6M meningitis, US$6.72M Ebola) in economic costs. Often, the more rapidly the ORI was initiated the greater impact.Interpretation ORI programmes are critical for reducing the health and economic impacts of outbreaks of vaccine-preventable diseases.https://gh.bmj.com/content/10/7/e016887.full
spellingShingle Stefanie Vaccher
Romesh G Abeysuriya
Nick Scott
Dominic Delport
Tewodaj Mengistu
Alina M Muellenmeister
Gabrielle MacKechnie
Dan Hogan
Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries
BMJ Global Health
title Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries
title_full Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries
title_fullStr Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries
title_full_unstemmed Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries
title_short Estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle-income countries
title_sort estimating the historical impact of outbreak response immunisation programmes across 210 outbreaks in low and middle income countries
url https://gh.bmj.com/content/10/7/e016887.full
work_keys_str_mv AT stefanievaccher estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries
AT romeshgabeysuriya estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries
AT nickscott estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries
AT dominicdelport estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries
AT tewodajmengistu estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries
AT alinammuellenmeister estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries
AT gabriellemackechnie estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries
AT danhogan estimatingthehistoricalimpactofoutbreakresponseimmunisationprogrammesacross210outbreaksinlowandmiddleincomecountries